Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease - Wikidata - awgldk - TriplyDB

Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease

Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease

http://www.wikidata.org/entity/Q35689983

about

Menopause, obesity and inflammation: interactive risk factors for Alzheimer's disease Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice In vivo imaging reveals sigmoidal growth kinetic of β-amyloid plaques.Extracellular phosphorylation of the amyloid β-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease.Protein phosphatase 5 protects neurons against amyloid-beta toxicity Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase Four decades of neurodegenerative disease research: how far we have come!Synapses and Alzheimer's disease Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease Imaging of Leukocyte Trafficking in Alzheimer's Disease Imaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence Imaging Tau Oligomers: The Toxic Player at Synapses in Alzheimer's Disease The Role of Oxidative Stress-Induced Epigenetic Alterations in Amyloid-β Production in Alzheimer's Disease Fibrillogenesis of huntingtin and other glutamine containing proteins The airbag problem-a potential culprit for bench-to-bedside translational efforts: relevance for Alzheimer's disease Development of positron emission tomography β-amyloid plaque imaging agents Regulation of macrophage and dendritic cell responses by their lineage precursors Sorting through the roles of beclin 1 in microglia and neurodegeneration Fibrillar amyloid plaque formation precedes microglial activation Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease.Disruption of axonal transport perturbs bone morphogenetic protein (BMP)--signaling and contributes to synaptic abnormalities in two neurodegenerative diseases Transnasal delivery of human A-beta peptides elicits impaired learning and memory performance in wild type mice.Microglia development and function Quantitative analysis of monocyte subpopulations in murine atherosclerotic plaques by multiphoton microscopy Huprine derivatives as sub-nanomolar human acetylcholinesterase inhibitors: from rational design to validation by X-ray crystallography Spines, plasticity, and cognition in Alzheimer's model mice Imaging calcium signals in vivo: a powerful tool in physiology and pharmacology.A Dormant Microbial Component in the Development of Preeclampsia Systems biology of neurodegenerative diseases Defining the earliest pathological changes of Alzheimer's disease ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease Deletion of the hemopexin or heme oxygenase-2 gene aggravates brain injury following stroma-free hemoglobin-induced intracerebral hemorrhage Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases Sequestration of the Abeta peptide prevents toxicity and promotes degradation in vivo CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation TGF-beta1 blockade of microglial chemotaxis toward Abeta aggregates involves SMAD signaling and down-regulation of CCL5 Prediction of Alzheimer's disease pathophysiology based on cortical thickness patterns Animal models for Alzheimer's disease and frontotemporal dementia: a perspective The NALP3 inflammasome is involved in the innate immune response to amyloid-beta

P2860

Q21131065-880E59A6-AE2F-4F17-B44B-5779F0ABF635 Q21142674-20412D60-9DA9-4184-95B6-41F831C7B231 Q22001055-47CD1038-F08D-4500-86D7-191AE8F0EEC8 Q24300656-5F4648C1-DAC8-4AD7-8AED-FC6EE95BD911 Q24615285-91EFDFB4-EF9C-41BD-80F8-2A91C9BAF803 Q24643985-05C32229-4121-4DBB-9C52-724A310AE7ED Q24645662-21B552E5-4315-415F-88C2-7D656905A6D0 Q26269868-78F80242-6D05-4DCB-9AAA-697A499C6011 Q26766462-49A56B73-CAFF-449C-8CA1-933451EDD260 Q26766489-BC9D9E5D-EC51-487A-8DA7-3B744CB3C4BF Q26770766-00227E36-D9E3-4894-BDF8-2EBAD609FDBB Q26773154-781C8966-0F89-4194-B7E2-C4B0D967A6BA Q26778776-CF6429FC-87D6-47DC-B2C5-CCEA80616894 Q26850062-4188D010-79BD-4880-8D39-23B7578B6179 Q26991654-F2F069C2-00AB-4E88-92D4-AAD1E5F94E79 Q27012742-DB56B551-326C-4DCE-BCD7-E3AD315ED3AD Q27022667-40E2C750-BC77-4A50-B75D-CD98AF092B6F Q27027712-75A6EC47-0593-40ED-A7A8-EC1FD8E0AA29 Q27311662-83F2D420-069F-4557-A469-48A731AA2C63 Q27311810-85F3DDC1-C5BB-40A6-BBEA-CA02AF75B693 Q27315692-FA80EB10-70ED-4ABA-B374-A68A8E31F6ED Q27315991-C5FEEC94-8CDE-4DA5-B104-68F384398A06 Q27316453-E29EDBDD-E124-4F7B-BB22-391B86C59B6B Q27319442-7EC4ECED-5668-4662-9D6C-84701F106C88 Q27675368-76075ACC-EF37-4B28-8A5A-9F9B2DBCBF4B Q27691328-5DDC12CE-06E7-4B7F-98FD-0190B5325DE2 Q27693266-74E07022-ACFD-4F33-8097-CEE76611FD67 Q28069689-876E451C-EAD7-4924-9BF7-68A691F72204 Q28080741-66FF6DD4-2E9C-4127-8CE9-8C756F0399AC Q28081435-644D121E-28DF-41AB-AD7E-B655524E9D15 Q28081654-AE6543F9-F05A-482E-9639-84544FC22D43 Q28261647-C1F138EC-6936-4BB5-86C7-365E4DB7EC80 Q28272786-D564D4C0-60C6-4B67-809B-7B67446B3109 Q28388335-F5E3B06D-A358-434F-9E26-5DDB37FD36CC Q28473205-D3BA3134-9E55-4630-82EB-91C2030793E5 Q28506984-BAE2650A-1EB5-4916-9390-174C1BB44F7A Q28568787-ED2B2461-C818-4836-9D12-8F1AC037D08E Q28602247-44DB8610-E565-40DF-BF1E-3C90F76AC710 Q28749702-12D1BDFD-EFFA-409D-82B7-2DB2A01D521E Q29615595-EBEB60EF-E75D-4C49-A3A4-B505CD884526

P2860

Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease

http://www.wikidata.org/entity/Q35689983

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Rapid appearance and local tox ...... e model of Alzheimer's disease

@ast

Rapid appearance and local tox ...... e model of Alzheimer's disease

@en

type

label

Rapid appearance and local tox ...... e model of Alzheimer's disease

@ast

Rapid appearance and local tox ...... e model of Alzheimer's disease

@en

prefLabel

Rapid appearance and local tox ...... e model of Alzheimer's disease

@ast

Rapid appearance and local tox ...... e model of Alzheimer's disease

@en

P1433

Q35689983-E2B78713-1249-4B14-9B70-04D017EDEECD

P1476

Q35689983-C5D337D7-63D6-41DB-BBA8-59C8672B5250

P2093

Q35689983-0276C306-9569-469B-A7B5-871961AF4267

Q35689983-904141E5-F4EF-43C1-A166-1A7BD71A76CE

Q35689983-AA194E2F-6B08-4DFE-99BE-839DBF8DF5C5

Q35689983-C6EF32D1-6293-4648-9140-6F56B002E69E

Q35689983-D033F7B0-9105-48E6-B9AF-EC8615F9EA53

P2860

Q35689983-0D970CAF-6A60-4B21-B4FD-CADF0152CAEA

Q35689983-1603D78D-BBDF-4931-A05D-BAC5C6836A75

Q35689983-31AB1413-7727-4E8A-ABFD-AAAA1B57F332

Q35689983-31C04C4D-7895-4BCC-921C-0F4097F997E4

Q35689983-3C3F779D-6918-47A3-B9B5-54267397E6B5

Q35689983-3FBE1B52-A80C-4F68-9516-94D59166EA9E

Q35689983-4B72D037-DBF4-4E70-A33A-7DD30FCBA8A4

Q35689983-5CE2957E-7B74-4318-8F75-A92639B81197

Q35689983-6584926D-BBA6-4403-80E1-C00E7A0A1E5D

Q35689983-751E0F11-6F68-45E3-AB04-1923A17A842E

P2888

Q35689983-0ACF1BD1-B261-49D8-BEAB-5B5F7F291B18

P304

Q35689983-156FE58C-C41C-41BC-AB00-4FE97BF29D3F

P31

Q35689983-0CF98240-AF4F-4499-B4DC-676AA04B3AAC

P356

Q35689983-8DC51A26-A608-4DDC-9F09-5F5593651C08

P407

Q35689983-B7A6D415-2E42-422C-BACA-35420C1CDD71

P433

Q35689983-29998AF2-554F-4B0D-B5BD-3B2A5547E293

P478

Q35689983-AD4731A8-F732-466F-8228-4D0EFE2F1569

P50

Q35689983-104DCAA5-8B9E-4669-8392-D1AEB5657792

Q35689983-1BF87737-D86D-41D8-B172-37BAEBDFEBC8

Q35689983-3A101612-EC0D-41B6-9B14-87A6C7FBBBE9

Q35689983-6EA6EB64-C403-4F3D-9A35-19E53B5020EE

Q35689983-EE205C93-7DA9-4CE8-989E-91B692040AF4

P577

Q35689983-0489C4A5-E728-41D9-815C-199B09109E35

P5875

Q35689983-0C295E46-1E26-44D1-909C-186C56D2C52F

P6179

Q35689983-DF432970-996F-4E38-AD67-72AF3C6DE36E

P698

Q35689983-40270EA0-934F-46A8-AC5B-5BDFA8A72ABB

P921

Q35689983-A278A356-57EC-46DB-A05B-434E25152ACC

P932

Q35689983-C06D5D9E-1EC0-4FFC-B496-947D28B40804

P356

P1433

P1476

Rapid appearance and local tox ...... e model of Alzheimer's disease

@en

P2093

Alix de Calignon

http://www.w3.org/2001/XMLSchema#string

Anete Rozkalne

http://www.w3.org/2001/XMLSchema#string

Brian J Bacskai

http://www.w3.org/2001/XMLSchema#string

Claudia Prada

http://www.w3.org/2001/XMLSchema#string

Jessica Koenigsknecht-Talboo

http://www.w3.org/2001/XMLSchema#string

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase

Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host

Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity

A specific amyloid-beta protein assembly in the brain impairs memory

Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

P2888

P304

720-724

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE06616

http://www.w3.org/2001/XMLSchema#string

P407

P433

7179

http://www.w3.org/2001/XMLSchema#string

P478

451

http://www.w3.org/2001/XMLSchema#string

P50

Melanie Meyer-Luehmann

Monica Garcia-Alloza

Tara L Spires-Jones

David M. Holtzman

P577

2008-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232783187

http://www.w3.org/2001/XMLSchema#string

P6179

1024411455

http://www.w3.org/2001/XMLSchema#string

P698

18256671

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3264491

http://www.w3.org/2001/XMLSchema#string